Devices › Device types
FDA product code MHY · class 3 · Unknown
Stimulator, electrical, implanted, for parkinsonian tremor: medical device reports filed with FDA
53,252 reports carry this product code, 1999–2026; 30 brands with a page.
- 53,252
- reports with this product code
- 0.2% of all MAUDE reports
- 3,380
- reports, 12 months to August 2026
- 3,372 in the 12 months before
- 50.2%
- classified as malfunction
- 62.3% across all reports
- 1.4%
- classified as death, as reported
- 0.9% across all reports
Product code MHY is FDA's classification for "Stimulator, electrical, implanted, for parkinsonian tremor" (unknown panel), a class 3 device. 53,252 medical device reports carry this product code, 0.2% of the MAUDE database, from April 1999 to August 2026.
3,380 reports arrived in the 12 months to August 2026, close to the 3,372 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (50.2%), injury (47.9%) and death (1.4%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medtronic Puerto Rico Operations | 15,164 | 28.5% |
| Medtronic Neuromodulation | 11,496 | 21.6% |
| Medtronic Med Rel Medtronic Puerto Rico | 8,310 | 15.6% |
| Abbott Medical | 3,000 | 5.6% |
| St Jude Medical - Neuromodulation | 1,918 | 3.6% |
| Boston Scientific Neuromodulation | 1,450 | 2.7% |
| Mdt Puerto Rico Operations Juncos | 1,380 | 2.6% |
| Mpri | 1,294 | 2.4% |
| Neuro - Villalba | 949 | 1.8% |
| Ipg Mfg Switzerland | 737 | 1.4% |
| Medtronic Europe Sarl | 707 | 1.3% |
| Mdt Puerto Rico Operations | 689 | 1.3% |
| Medtronic Puerto Rico Villalba | 318 | 0.6% |
| Medtronic Puerto Rico Operations Juncos | 299 | 0.6% |
| St Jude Medical - Neuromodulation Puerto Rico | 250 | 0.5% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| High impedance | 7,341 | 13.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 5,009 | 9.4% |
| Battery problema problem with the battery | 3,851 | 7.2% |
| Failure to deliver energy | 3,041 | 5.7% |
| Connection problema connection problem | 2,901 | 5.4% |
| Insufficient device problem information | 2,890 | 5.4% |
| Low impedance | 2,585 | 4.9% |
| Charging problem | 2,570 | 4.8% |
| Inappropriate/inadequate shock/stimulation | 2,435 | 4.6% |
| Breakthe device broke | 2,427 | 4.6% |
| Material integrity problema problem with the device material | 2,373 | 4.5% |
| Communication or transmission problemthe device could not communicate or transmit | 1,990 | 3.7% |
| Device displays incorrect message | 1,464 | 2.7% |
| Migration or expulsion of device | 1,435 | 2.7% |
| Premature discharge of battery | 1,426 | 2.7% |
| Electromagnetic compatibility problem | 1,258 | 2.4% |
| Impedance problem | 1,171 | 2.2% |
| Unintended collision | 1,154 | 2.2% |
| Malposition of device | 1,005 | 1.9% |
| Electromagnetic interference | 988 | 1.9% |
Questions about stimulator, electrical, implanted, for parkinsonian tremor reports
What is product code MHY?
FDA's classification code for "Stimulator, electrical, implanted, for parkinsonian tremor", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
53,252 reports through August 2026, 3,380 of them in the latest 12 months.
Which brands appear most often?
Activa (26,242), Soletra (4,531), Percept (2,937), Implantable Neurostimulator (2,421) and Kinetra (2,136). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.